Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacology
|
May 23, 2002
Electrocardiographic effects of rivastigmine
Joel Morganroth, Stephen Graham, Richard Hartman, et al.
Child Maltreatment
|
June 23, 2026
Professional Perceptions of Problematic Sexual Behavior in Children
Caitlyn N Muniz, Richard Hartman, Michelle N Jeanis
Brain Research
|
May 26, 2009
Assessing functional outcomes following intracerebral hemorrhage in rats
Richard Hartman, Tim Lekic, Hugo Rojas, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 22, 2002
Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease
Steven G Potki, Ravi Anand, Richard Hartman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2003
Impact of study design and patient population on outcomes from cholinesterase inhibitor trials
Ravi Anand, Richard Hartman, Hyesung Sohn, et al.
Nutrients
|
July 2, 2021
Healthy Food on Instagram Social Network: Vegan, Homemade and Clean Eating
Ladislav Pilař, Lucie Kvasničková Stanislavská, Roman Kvasnička, et al.
Stroke
|
January 16, 2014
Inhibition of transforming growth factor-β attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage
Anatol Manaenko, Tim Lekic, Margaret Barnhart, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
March 12, 2004
Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening
Murray Raskind, Vinod Kumar, Lisa Malaty, et al.
Therapeutic Advances in Psychopharmacology
|
January 29, 2026
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials
Ravi Anand, Alessio Turolla, Giovanni Chinellato, et al.
Journal of Psychosomatic Research
|
February 24, 2020
Adverse childhood experiences and depressive symptoms: Protective effects of dietary flavonoids
Alison Tan, Kelly R Morton, Jerry W Lee, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacology
|
May 23, 2002
Electrocardiographic effects of rivastigmine
Joel Morganroth, Stephen Graham, Richard Hartman, et al.
Child Maltreatment
|
June 23, 2026
Professional Perceptions of Problematic Sexual Behavior in Children
Caitlyn N Muniz, Richard Hartman, Michelle N Jeanis
Brain Research
|
May 26, 2009
Assessing functional outcomes following intracerebral hemorrhage in rats
Richard Hartman, Tim Lekic, Hugo Rojas, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 22, 2002
Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease
Steven G Potki, Ravi Anand, Richard Hartman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2003
Impact of study design and patient population on outcomes from cholinesterase inhibitor trials
Ravi Anand, Richard Hartman, Hyesung Sohn, et al.
Nutrients
|
July 2, 2021
Healthy Food on Instagram Social Network: Vegan, Homemade and Clean Eating
Ladislav Pilař, Lucie Kvasničková Stanislavská, Roman Kvasnička, et al.
Stroke
|
January 16, 2014
Inhibition of transforming growth factor-β attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage
Anatol Manaenko, Tim Lekic, Margaret Barnhart, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
March 12, 2004
Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening
Murray Raskind, Vinod Kumar, Lisa Malaty, et al.
Therapeutic Advances in Psychopharmacology
|
January 29, 2026
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials
Ravi Anand, Alessio Turolla, Giovanni Chinellato, et al.
Journal of Psychosomatic Research
|
February 24, 2020
Adverse childhood experiences and depressive symptoms: Protective effects of dietary flavonoids
Alison Tan, Kelly R Morton, Jerry W Lee, et al.
Page
of 4